QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors in the context of biomarkers, drug targets and pathways

65 views
May 11, 2023
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you’ll learn how to:

· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases

· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, or a particular disease/disease subtype and others)

· Correlate expression of multiple genes and biomarkers

· Compare different experimental groups (e.g., your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

32 views September 06, 2023

In this 90-minute training, you'll learn how to perform drug treatment,...

QIAGEN OmicSoft and Biomedical Knowledge Base

Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis

56 views August 16, 2023

Research and development for new drugs and disease treatments can be lengthy...

QIAGEN OmicSoft and Biomedical Knowledge Base

Target exploration and cell line selection for drug discovery

83 views July 21, 2023

Cancer cell line models have been a cornerstone of cancer research for...

QIAGEN OmicSoft and Biomedical Knowledge Base

Study of public data on inflammatory conditions public data for biomarker and drug target...

75 views June 22, 2023

In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis...